Payments from the European budget should be possible only if the activities they finance respect: social rights, minimum wage, safety at work, occupational safety, health, work-life balance and organisation of working time.
With citizens struggling to cope with the increasing cost of living, S&D Parliamentary leaders are committing to building a fairer and more progressive Europe that improves people’s lives.
The International Council for Harmonisation (ICH) has initiated the process for a new guideline on bioequivalence requirements for the approval of medicines, which is an important milestone for global convergence. The EU Pharmaceutical Strategy for Europe can build on this to enable global generic medicine development which is needed for better access to medicines and security of supply.
The S&Ds welcome the long-awaited legislative proposals for the much-needed reform of the EU fiscal rules presented today by the European Commission. It is positive in that the proposals foresee more flexibility for strategic investments and allow for different member states' debt reduction paths.
Today, MEPs in the civil liberties, justice and home affairs committee have sent the European institutions a warning about the significant shortcomings in public access to documents. In a report drafted by S&D member Evin Incir, MEPs call for transparency to be the rule in the EU, not the exception.
The European Parliament is ready to negotiate for asbestos-free work. Today, its employment committee agreed on a strong mandate for talks with EU member states on the revised European law on the protection of workers from asbestos.
Today, members of the European Parliament special committee on foreign interference and disinformation (INGE) - set up on the initiative of the S&D Group in 2020 - voted its second report with concrete recommendations on how to protect the democratic process from malicious foreign actors, and particularly from Russia and China.
Tomorrow, the European Commission will announce the long-awaited new pharmaceutical package aimed at improving access, availability and affordability of medicines for EU citizens.
